Regulation of Patient Management Software. Regulation of Patient Management Software.

Regulation of Patient Management Software‪.‬

Health Law Journal 2010, Annual, 18

    • £2.99
    • £2.99

Publisher Description

1 Introduction Faced with rising service costs and aging populations, governments and health care organizations in North America and Europe have little choice but to improve the efficiency and efficacy of medical care delivery. While culprits abound, research has shown that many inefficiencies and quality problems arise from a lack of access to relevant information. Common examples include unnecessary duplication of laboratory work, cancellation of scheduled treatments on account of missing data, and prescription of unnecessary (or even harmful) drugs. As a result of these concerns, governments and health organizations are investing in the development and acquisition of information and communications technology (ICT), including decision support systems, electronic medical record (EMR) software, and telemedicine. While these initiatives promise benefits for health care delivery, the use of software systems in the health care domain raises new concerns about safety, effectiveness, privacy, and security. Of these issues, safety and effectiveness are perhaps the most important. Research studies have estimated that medical errors result in up to 98,000 deaths each year in the United States, with costs approximated to $30 billion. (1) Unfortunately, experience has shown that software systems have the potential to generate life-threatening errors. (2)

GENRE
Health & Well-Being
RELEASED
2010
1 January
LANGUAGE
EN
English
LENGTH
59
Pages
PUBLISHER
Health Law Institute
SIZE
261.6
KB

More Books Like This

From Principle to Practice: Bugs, Drugs & Attachments From Principle to Practice: Bugs, Drugs & Attachments
2013
Safeguarding Health Care: Responsible for Device Approvals, Recalls, And Inspections, The FDA Continues to Streamline and Improve Its Strategies Safeguarding Health Care: Responsible for Device Approvals, Recalls, And Inspections, The FDA Continues to Streamline and Improve Its Strategies
2008
New Health Technologies New Health Technologies
2017
E-Health E-Health
2010
The Curious Case of Off-Label Use (At Law) The Curious Case of Off-Label Use (At Law)
2007
The Role of Food and Drug Administration Regulation of in Vitro Diagnostic Devices--Applications to Genetics Testing (Clinical Chemistry Forum) The Role of Food and Drug Administration Regulation of in Vitro Diagnostic Devices--Applications to Genetics Testing (Clinical Chemistry Forum)
1999

More Books by Health Law Journal

All in the Family: A Child Welfare Perspective on Human Reproductive Cloning. All in the Family: A Child Welfare Perspective on Human Reproductive Cloning.
2003
Behind the Screen: Legal and Ethical Considerations in Neonatal Screening for Prenatal Exposure to Alcohol (Canada) Behind the Screen: Legal and Ethical Considerations in Neonatal Screening for Prenatal Exposure to Alcohol (Canada)
2006
History of a Gene Patent: Tracing the Development and Application of Commercial BRCA Testing (Myriad Genetics) History of a Gene Patent: Tracing the Development and Application of Commercial BRCA Testing (Myriad Genetics)
2002
Reconciling Private Benefit and Public Risk in Biotechnology: Xenotransplantation As a Case Study in Consent. Reconciling Private Benefit and Public Risk in Biotechnology: Xenotransplantation As a Case Study in Consent.
2002
A Place for Criminal Law in the Regulation of Reproductive Technologies (Canada ) A Place for Criminal Law in the Regulation of Reproductive Technologies (Canada )
2002
Lost in Translation: The Canadian Access to Medicines Regime from Transnational Activism to Domestic Implementation. Lost in Translation: The Canadian Access to Medicines Regime from Transnational Activism to Domestic Implementation.
2010